Servoteach Industries Limited (SERVOTEACH.BO)
INR 20.96
(-4.86%)
INR 20.96
(-4.86%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | - INR | -25.0% |
| 2022 | -1.00 INR | -700.0% |
| 2021 | -1.00 INR | -5.93% |
| 2020 | -0.94 INR | 99.38% |
| 2019 | -151.06 INR | -20822.44% |
| 2018 | -0.72 INR | 90.97% |
| 2017 | -8.00 INR | -443.34% |
| 2016 | -1.47 INR | 99.9% |
| 2015 | -1449.05 INR | -28.89% |
| 2014 | -1124.27 INR | -74.76% |
| 2013 | -643.31 INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1330.00 INR | -132900.0% |
| 2023 Q4 | -1.00 INR | 100.0% |
| 2023 FY | - INR | -25.0% |
| 2023 Q1 | -258.74 Thousand INR | -2874800.0% |
| 2023 Q3 | -344.65 Thousand INR | 29.01% |
| 2023 Q2 | -485.51 Thousand INR | -87.64% |
| 2022 FY | - INR | -700.0% |
| 2022 Q1 | - INR | 100.0% |
| 2022 Q3 | -161.83 Thousand INR | 19.8% |
| 2022 Q2 | -201.79 Thousand INR | 0.0% |
| 2022 Q4 | -9.00 INR | 99.99% |
| 2021 Q3 | - INR | 0.0% |
| 2021 Q4 | -1.00 INR | 0.0% |
| 2021 Q2 | - INR | 0.0% |
| 2021 Q1 | - INR | 100.0% |
| 2021 FY | - INR | -5.93% |
| 2020 Q3 | - INR | 0.0% |
| 2020 Q1 | - INR | 100.0% |
| 2020 FY | - INR | 99.38% |
| 2020 Q4 | -0.94 INR | 0.0% |
| 2020 Q2 | - INR | 0.0% |
| 2019 Q2 | - INR | 0.0% |
| 2019 FY | - INR | -20822.44% |
| 2019 Q3 | - INR | 0.0% |
| 2019 Q1 | - INR | 100.0% |
| 2019 Q4 | -151.06 INR | 0.0% |
| 2018 Q2 | - INR | 0.0% |
| 2018 FY | - INR | 90.97% |
| 2018 Q1 | - INR | 100.0% |
| 2018 Q3 | - INR | 0.0% |
| 2018 Q4 | -0.72 INR | 0.0% |
| 2017 Q1 | - INR | 100.0% |
| 2017 Q2 | - INR | 0.0% |
| 2017 Q4 | -8.00 INR | 0.0% |
| 2017 Q3 | - INR | 0.0% |
| 2017 FY | - INR | -443.34% |
| 2016 Q2 | - INR | 0.0% |
| 2016 Q1 | - INR | 100.0% |
| 2016 FY | - INR | 99.9% |
| 2016 Q4 | -1.47 INR | 0.0% |
| 2016 Q3 | - INR | 0.0% |
| 2015 Q4 | -333.55 INR | 4.2% |
| 2015 FY | - INR | -28.89% |
| 2015 Q3 | -348.17 INR | 11.22% |
| 2015 Q2 | -392.17 INR | -4.02% |
| 2015 Q1 | -377.00 INR | 17.1% |
| 2014 Q2 | -315.74 INR | -64.45% |
| 2014 Q3 | -171.74 INR | 45.61% |
| 2014 Q4 | -454.77 INR | -164.8% |
| 2014 FY | - INR | -74.76% |
| 2014 Q1 | -192.00 INR | -177.86% |
| 2013 Q4 | -69.10 INR | 59.54% |
| 2013 Q3 | -170.78 INR | -4.91% |
| 2013 Q2 | -162.78 INR | 0.0% |
| 2013 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 10.12 Million INR | 100.0% |
| Biocon Limited | 41.52 Billion INR | 100.0% |
| Blue Jet Healthcare Limited | 2.29 Billion INR | 100.0% |
| Concord Biotech Limited | 4.65 Billion INR | 100.0% |
| Dishman Carbogen Amcis Limited | 3.07 Billion INR | 100.0% |
| FERMENTA BIOTECH LIMITED | 262.68 Million INR | 100.0% |
| GENOMIC VALLEY BIOTECH LIMITED | 147.4 Thousand INR | 100.0% |
| Lyka Labs Limited | 167.58 Million INR | 100.0% |
| Panacea Biotec Limited | -200.6 Million INR | 100.0% |
| SAMSRITA LABS LIMITED | -2.46 Million INR | 100.0% |
| SMS Lifesciences India Limited | 349.41 Million INR | 100.0% |
| Supriya Lifescience Limited | 1.83 Billion INR | 100.0% |
| Syngene International Limited | 10.84 Billion INR | 100.0% |
| TAKE Solutions Limited | -1.05 Billion INR | 100.0% |
| Titan Biotech Limited | 360.29 Million INR | 100.0% |
| Transgene Biotek Limited | -4.33 Million INR | 100.0% |
| Vanta Bioscience Limited | 14.19 Million INR | 100.0% |